KENDALL DUET: Open Payments
NPI 1447797279 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $129 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: FANAPT, Qelbree, Kerendia, MOUNJARO, ELIQUIS, Wegovy.
Industry payments across LA — which companies pay providers there.
